Physician profile
Crystal L Rogers
NPI 1396115465
$570.37
in general payments reported to CMS, 2019-2025
14 companies · $85.98 in 2025
The $85.98 reported for 2025 was less than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $245 · 2022: $17.60 · 2023: $152 · 2024: $69.72 · 2025: $85.98.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $265 · Education: $43.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $264.61 |
| Education | $43.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $116.18 | 2021 | |
| Novartis Pharmaceuticals Corporation | $92.50 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $78.08 | 2021-2025 | Enhertu |
| E.R. Squibb & Sons, L.L.C. | $60.16 | 2021-2024 | Krazati |
| Gilead Sciences, INC. | $49.68 | 2023 | Trodelvy |
| Merck Sharp & Dohme LLC | $24.46 | 2024 | Keytruda |
| Glaxosmithkline, LLC. | $22.53 | 2021 | |
| Celgene Corporation | $22.50 | 2024 | Reblozyl |
| Cti Biopharma Corp. | $20.80 | 2023 | Vonjo |
| Amgen INC. | $19.98 | 2021 | |
| Seagen INC. | $17.59 | 2023 | Padcev |
| Array Biopharma INC | $16.01 | 2021 | |
| Lilly USA, LLC | $15.58 | 2021 | |
| Genentech USA, INC. | $14.32 | 2023 | Polivy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Crystal Rogers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.